{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:04:06Z","timestamp":1772280246153,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012380","name":"Lerner Research Institute, Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.eprac.2021.10.003","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T01:46:57Z","timestamp":1634867217000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Weight-Based Insulin During and After Intravenous Insulin Infusion Reduces Rates of Rebound Hyperglycemia When Transitioning to Subcutaneous Insulin in the Medical Intensive Care Unit"],"prefix":"10.1016","volume":"28","author":[{"given":"Keren","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren Anne","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin","family":"Zaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Cecilia","family":"Lansang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eprac.2021.10.003_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.eprac.2021.01.016","article-title":"Inpatient hyperglycemia and transitions of care: a systematic review","volume":"27","author":"Lansang","year":"2021","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.eprac.2021.10.003_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/dc10-2023","article-title":"Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome","volume":"34","author":"Avanzini","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2021.10.003_bib3","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","article-title":"Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients","volume":"40","author":"Jacobi","year":"2012","journal-title":"Crit Care Med"},{"issue":"5 suppl","key":"10.1016\/j.eprac.2021.10.003_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jhm.355","article-title":"Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia","volume":"3","author":"O\u2019Malley","year":"2008","journal-title":"J\u00a0Hosp Med"},{"issue":"8","key":"10.1016\/j.eprac.2021.10.003_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jhm.810","article-title":"Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach","volume":"5","author":"Ramos","year":"2010","journal-title":"J\u00a0Hosp Med"},{"issue":"5","key":"10.1016\/j.eprac.2021.10.003_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4158\/EP.12.5.491","article-title":"Inpatient management of hyperglycemia: the Northwestern experience","volume":"12","author":"DeSantis","year":"2006","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2021.10.003_bib7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/1932296816629985","article-title":"Transition from intravenous to subcutaneous insulin in critically ill adults","volume":"10","author":"Doolin","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2021.10.003_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP11027.OR","article-title":"Comparison of 3 algorithms for basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery","volume":"17","author":"Dungan","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2021.10.003_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/193229680900300311","article-title":"Cleveland Clinic cardiovascular intensive care unit insulin conversion protocol","volume":"3","author":"Olansky","year":"2009","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2021.10.003_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP.12.6.641","article-title":"Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia","volume":"12","author":"Schmeltz","year":"2006","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2021.10.003_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1345\/aph.1Q698","article-title":"Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial","volume":"47","author":"Silinskie","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.eprac.2021.10.003_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1345\/aph.1L629","article-title":"Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients","volume":"43","author":"Weant","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eprac.2021.10.003_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.diabres.2017.05.016","article-title":"Transitioning from intravenous to subcutaneous insulin in the medical intensive care unit","volume":"134","author":"Zhou","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.eprac.2021.10.003_bib14","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2012-1244","article-title":"Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia","volume":"97","author":"Hsia","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2021.10.003_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dme.13675","article-title":"Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group","volume":"35","author":"Roberts","year":"2018","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.eprac.2021.10.003_bib16","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis","volume":"37","author":"Falciglia","year":"2009","journal-title":"Crit Care Med"},{"issue":"13","key":"10.1016\/j.eprac.2021.10.003_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2021.10.003_bib18","first-page":"S211","article-title":"Diabetes care in the hospital: standards of medical care in diabetes-2021","volume":"43","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2021.10.003_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11892-015-0595-4","article-title":"Transitioning safely from intravenous to subcutaneous insulin","volume":"15","author":"Kreider","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10.1016\/j.eprac.2021.10.003_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0884533615591057","article-title":"Management of hyperglycemia and enteral nutrition in the hospitalized patient","volume":"30","author":"Davidson","year":"2015","journal-title":"Nutr Clin Pract"},{"issue":"8","key":"10.1016\/j.eprac.2021.10.003_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-017-0882-3","article-title":"Nutrition and hyperglycemia management in the inpatient setting (meals on demand, parenteral, or enteral nutrition)","volume":"17","author":"Drincic","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"10","key":"10.1016\/j.eprac.2021.10.003_bib22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4158\/EP-2018-0150","article-title":"The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition","volume":"24","author":"Vennard","year":"2018","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2021.10.003_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/dc08-1436","article-title":"Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial","volume":"32","author":"Korytkowski","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2021.10.003_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0884533611420727","article-title":"Comparison of 70\/30 biphasic insulin with glargine\/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy","volume":"26","author":"Hsia","year":"2011","journal-title":"Nutr Clin Pract"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21012623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21012623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:11Z","timestamp":1761516791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21012623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1530891X21012623"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.10.003","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight-Based Insulin During and After Intravenous Insulin Infusion Reduces Rates of Rebound Hyperglycemia When Transitioning to Subcutaneous Insulin in the Medical Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}